Attendee search 

Health and wellbeing cluster is a development platform for the health and wellbeing companies and other organizations. The cluster is supported by the Ministry of Employment and the Economy and the cities of Kuopio, Oulu, Tampere and Helsinki. The cluster brings together app. 600 companies, several universities, hospitals, financiers and other organizations. Our focus is to support creation of new innovations and to increase competitiveness of the private companies through innovations. The society gets benefit through new service models and technology which save recourses. We welcome all international companies and organizations to participate our activities which you’ll  find on our webpages www.hyvinvointiklusteri.fi

Onbone Oy (“Onbone” or the “Company”), is a Finnish life science company founded in 2008 and based in Helsinki, Finland. Company launched it´s first product, WOODCAST® Splint intended for upper limb immobilization, in mid-2010 to Finnish markets. Since then WOODCAST® has grown into comprehensive range of casting products which are available in 11 countries across Europe with over 40 000 units shipped to date. Onbone is owned by its founders and Inveni Capital, a Finnish-German life science venture fund.

WOODCAST® products are based on significant proprietary technology and are protected by a robust patent portfolio. The Company has filed five patents covering the wood composite material, its application in orthopedics and its production.

Currently orthopedic casting is made with either plaster or glass fiber type synthetic casting products which both represent technology dating back several decades. The main problems associated with plaster and glass fiber products are messy time consuming application procedure and occupational safety risk for users posed by toxic components. However, due to lack of alternative products they are still used all over the world today.

The Company’s WOODCAST® product line represents a breakthrough technology and is the first significant cast innovation in decades with potential to gain substantial share in the highly profitable fracture treatment and orthopedic support market. WOODCAST® products are easy-to-use, non-toxic and biodegradable and have received enthusiastic responses from health care professionals all over.

For hospitals Woodcast offers increased safety and cost efficiency of the cast room operation. Additionally increasing number of hospitals have adopted environmentally sustainable product management strategies which favor the use of ecological/biodegradable alternatives when available, making Woodcast the only option.

During three first years on the market in Finland, Woodcast has been installed to 80 % of hospitals and sales have grown in three digit rate annually. Since launch in Germany in early 2013, Woodcast has been installed to dozens of hospitals and over 100 hospitals are on a waiting list to have a product trial.

The global addressable market for Woodcast products is € 1,5 billion from which 2/3 is in EU and US. Market is dominated by 3 global players; BSN Medical, 3M and Lohmann&Rauscher. Typical life cycle of a medical device start-up is to be acquired by a global player after commercial proof has been established.

Onbone is now seeking funding to finance expansion of distribution network in key markets; EU and US.

Magnasense Technologies Oy

Superior immunoassay performance utilising paramagnetic labels - MagneticImmunoAssay (MIA).

Magnasense has developed a sensitive, simple and elegant system for performing lateral flow immunoassays utilising paramagnetic particles as labels.

Biological materials contain no background magnetism, enabling great sensitivity, while the elimination of chemical, enzymatic and fluorescent reagents simplifies the assay procedure.

The magnetic label interacts directly with the reader’s electronics eliminating the need for light sources and optics.

The above factors provide a uniquely sensitive, robust and inexpensive system.

The system is widely applicable. Quantitative, Near Patient / Point of Care (POC) assays and tests can be rapidly developed with high sensitivity and dynamic ranges of over four decades.
Healthcare applications include cardiac monitoring, e.g. hsCRP and infectious diseases, e.g. viruses.

Outside healthcare, assays can be developed for other applications where rapid results are required, such as veterinary testing, and food and environmental contamination

Applications:
Near Patient Testing, Point of Care Testing, Veterinary Testing, Mould / Mycotoxin testing, Food adulteration, Environmental testing

SpinChip Diagnostics will market the new state of the art platform for in vitro diagnostics (IVD) point of care (PoC) analysis. The technology will provide significant value by enabling faster, easier and more reliable PoC analysis at hospitals and in decentralized medical settings.